XML 32 R8.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Statements of Consolidated Changes in Equity (Unaudited) - USD ($)
$ in Millions
Total
Cumulative Preferred Stock
Common Stock
Additional Paid-in-Capital
Retained Earnings
Accumulated Other Comprehensive Loss
Series A Preferred Stock
Series A Preferred Stock
Cumulative Preferred Stock
Balance, beginning of period (in shares) at Dec. 31, 2021   1,000,000            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Redemption of Series A Preferred Stock (in shares)               0
Redemption of Series A Preferred Stock               $ 0
Balance, beginning of period at Dec. 31, 2021   $ 790 $ 6 $ 8,529 $ 154 $ (64)    
Balance, beginning of period (in shares) at Dec. 31, 2021     629,000,000          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuances related to benefit and investment plans (in shares)     0          
Issuances related to benefit and investment plans     $ 0 28        
Net income $ 923       923      
Common Stock dividends declared (see Note 18)         (334)      
Preferred Stock dividends declared (see Note 18)         (24)      
Other comprehensive loss           (19)    
Balance, end of period (in shares) at Sep. 30, 2022   1,000,000            
Balance, end of period at Sep. 30, 2022 9,989 $ 790 $ 6 8,557 719 (83)    
Balance, end of period (in shares) at Sep. 30, 2022     629,000,000          
Balance, beginning of period (in shares) at Jun. 30, 2022   1,000,000            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Redemption of Series A Preferred Stock (in shares)               0
Redemption of Series A Preferred Stock               $ 0
Balance, beginning of period at Jun. 30, 2022   $ 790 $ 6 8,544 768 (85)    
Balance, beginning of period (in shares) at Jun. 30, 2022     629,000,000          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuances related to benefit and investment plans (in shares)     0          
Issuances related to benefit and investment plans     $ 0 13        
Net income 202       202      
Common Stock dividends declared (see Note 18)         (227)      
Preferred Stock dividends declared (see Note 18)         (24)      
Other comprehensive loss           2    
Balance, end of period (in shares) at Sep. 30, 2022   1,000,000            
Balance, end of period at Sep. 30, 2022 $ 9,989 $ 790 $ 6 8,557 719 (83)    
Balance, end of period (in shares) at Sep. 30, 2022     629,000,000          
Balance, beginning of period (in shares) at Dec. 31, 2022 800,000 1,000,000         800,000  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Redemption of Series A Preferred Stock (in shares)               (1,000,000)
Redemption of Series A Preferred Stock               $ (790)
Balance, beginning of period at Dec. 31, 2022 $ 10,042 $ 790 $ 6 8,568 709 (31)    
Balance, beginning of period (in shares) at Dec. 31, 2022 629,535,631   630,000,000          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuances related to benefit and investment plans (in shares)     1,000,000          
Issuances related to benefit and investment plans     $ 0 13        
Net income $ 725       725      
Common Stock dividends declared (see Note 18)         (366)      
Preferred Stock dividends declared (see Note 18)         (41)      
Other comprehensive loss           2    
Balance, end of period (in shares) at Sep. 30, 2023 0 0         0  
Balance, end of period at Sep. 30, 2023 $ 9,585 $ 0 $ 6 8,581 1,027 (29)    
Balance, end of period (in shares) at Sep. 30, 2023 631,209,962   631,000,000          
Balance, beginning of period (in shares) at Jun. 30, 2023   1,000,000            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Redemption of Series A Preferred Stock (in shares)               (1,000,000)
Redemption of Series A Preferred Stock               $ (790)
Balance, beginning of period at Jun. 30, 2023   $ 790 $ 6 8,570 1,032 (32)    
Balance, beginning of period (in shares) at Jun. 30, 2023     631,000,000          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuances related to benefit and investment plans (in shares)     0          
Issuances related to benefit and investment plans     $ 0 11        
Net income $ 282       282      
Common Stock dividends declared (see Note 18)         (246)      
Preferred Stock dividends declared (see Note 18)         (41)      
Other comprehensive loss           3    
Balance, end of period (in shares) at Sep. 30, 2023 0 0         0  
Balance, end of period at Sep. 30, 2023 $ 9,585 $ 0 $ 6 $ 8,581 $ 1,027 $ (29)    
Balance, end of period (in shares) at Sep. 30, 2023 631,209,962   631,000,000